Home > Insider Trading > Filing (0001209191-21-042802)

Filing Details

Accession Number:: 0001209191-21-042802
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-23 17:38:53
Reporting Period:: 2021-06-21

Accepted Time:: 2021-06-23 17:38:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1808158	Repare Therapeutics Inc.	RPTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1473930	Todd Foley	C/O Mpm Capital 450 Kendall Street Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2021-06-21	2,556	$33.80	2,307,390	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-06-21	14,006	$34.63	2,293,384	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-06-22	1,486	$33.36	2,291,898	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-06-22	189	$34.09	2,291,709	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-06-23	622	$32.98	2,291,087	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on 3/31/2021.
The shares were sold as follows: 2,471 by MPM BioVentures 2014, L.P. ("BV 2014") and 85 by MPM Asset Management Investors BV2014 LLC ("AM BV2014").
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.33 to $34.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held as follows: 2,099,289 by BV 2014, 135,843 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)") and 72,258 by AM BV2014. MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). BV LLC is the manager of AM BV2014. Todd Foley is a managing director of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 13,540 by BV 2014 and 466 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.39 to $34.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held as follows: 2,085,749 by BV 2014, 135,843 by BV 2014(B) and 71,792 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 1,436 by BV 2014 and 50 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.95 to $33.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held as follows: 2,084,313 by BV 2014, 135,843 by BV 2014(B) and 71,742 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 183 by BV 2014 6 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.98 to $34.16 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held as follows: 2,084,130 by BV 2014, 135,843 by BV 2014(B) and 71,736 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 601 by BV 2014 and 21 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.95 to $33.03 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held as follows: 2,083,529 by BV 2014, 135,843 by BV 2014(B) and 71,715 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.